These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34726776)

  • 1. Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic.
    Cazzaniga S; Naldi L
    Br J Dermatol; 2022 Jan; 186(1):7-8. PubMed ID: 34726776
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.
    Penso L; Dray-Spira R; Weill A; Zureik M; Sbidian E
    Br J Dermatol; 2022 Jan; 186(1):59-68. PubMed ID: 34310699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of infections in psoriasis. A lesson to learn during the SARS-CoV-2 pandemic.
    Naldi L
    Br J Dermatol; 2021 Jan; 184(1):6. PubMed ID: 32538461
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical management of psoriasis patients during the COVID-19 pandemic.
    Chat VS; Uppal SK; Kearns DG; Wu JJ
    J Dermatolog Treat; 2022 Mar; 33(2):1166-1167. PubMed ID: 32568009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic.
    Penso L; Dray-Spira R; Weill A; Zureik M; Sbidian E
    Br J Dermatol; 2021 Sep; 185(3):671-673. PubMed ID: 33894022
    [No Abstract]   [Full Text] [Related]  

  • 6. [BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].
    Kruglova LS; Pereverzina NO; Rudneva NS; Kamynina NN; Oynotkinova OS
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1381-1387. PubMed ID: 34792893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
    Rosi E; Pimpinelli N; Prignano F
    J Dermatolog Treat; 2022 Feb; 33(1):599. PubMed ID: 32432955
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort.
    Arlegui H; Mahé E; Richard MA; De Rycke Y; Viguier M; Beylot-Barry M; Dupuy A; Beneton N; Joly P; Jullien D; Bachelez H; Sbidian É; Chosidow O; Paul C; Tubach F;
    Ann Dermatol Venereol; 2023 Jun; 150(2):101-108. PubMed ID: 36914553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.
    Sadeghinia A; Daneshpazhooh M
    Dermatol Ther; 2021 Jan; 34(1):e14498. PubMed ID: 33141519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the editor regarding the article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.".
    Potestio L; Camela E; Tajani A; Fabbrocini G; Megna M
    J Cosmet Dermatol; 2022 Mar; 21(3):880-882. PubMed ID: 35037352
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for treatment of nail psoriasis during the COVID-19 pandemic.
    Ricardo JW; Lipner SR
    Dermatol Ther; 2020 Jul; 33(4):e13757. PubMed ID: 32495952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study.
    Oguz Topal I; Kara Polat A; Zindancı İ; Kıvanç Altunay İ; Akbulut TÖ; Arıkan EE; Topaloğlu Demir F; Sivaz O; Karadağ AS
    J Cosmet Dermatol; 2022 Jan; 21(1):39-47. PubMed ID: 34792848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
    Ladda M; Lynde C; Fleming P
    J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.
    Polat Ekinci A; Pehlivan G; Gökalp MO
    Dermatol Ther; 2021 Jan; 34(1):e14700. PubMed ID: 33369063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of SARS-CoV-2 Virus Infection on the Course of Psoriasis during Treatment with Biological Drugs.
    Mroz M; Mućka S; Miodońska M; Ziolkowska D; Hadas E; Bożek A
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577804
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course.
    Yalici-Armagan B; Tabak GH; Dogan-Gunaydin S; Gulseren D; Akdogan N; Atakan N
    J Cosmet Dermatol; 2021 Oct; 20(10):3098-3102. PubMed ID: 34365714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of COVID-19 pandemic on psoriasis patients in northern Greece.
    Apalla Z; Fotiadou C; Emvalomati A; Patsatsi A; Trakatelli M; Trigoni A; Kyrgidis A; Trakatelli C; Papazisis G; Lallas A; Droggoula O; Giannakaki MM; Oflidou V; Siskou S; Boziou M; Karydi K; Daponte A; Kemanetzi C; Tsatsou F; Kyrmanidou E; Lazaridou E
    Dermatol Ther; 2022 Feb; 35(2):e15244. PubMed ID: 34862701
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.
    Conforti C; Giuffrida R; Dianzani C; Di Meo N; Zalaudek I
    Dermatol Ther; 2020 Jul; 33(4):e13490. PubMed ID: 32358864
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of systemic therapies for psoriasis in the COVID-19 era.
    Kearns DG; Uppal S; Chat VS; Wu JJ
    J Dermatolog Treat; 2022 Mar; 33(2):622-625. PubMed ID: 32459567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.
    Kado S; Kamiya K; Kishimoto M; Maekawa T; Kuwahara A; Sugai J; Komine M; Ohtsuki M
    J Dermatol; 2021 Dec; 48(12):1907-1912. PubMed ID: 34549456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.